ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,291.34
0.15%
US Tech 100
18,208.00
0.46%
다우존스 지수
38,711.29
0.36%
Bitcoin
70,953.25
0.47%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Verona Pharma Plc (VRNA)

  7. Verona Pharma Plc (VRNA) 뉴스

VRNA

Verona Pharma (VRNA)

Verona Pharma Plc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VRNA
일자시간출처헤드라인심볼기업
2024/05/1022:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRNAVerona Pharma Plc
2024/05/1021:53Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRNAVerona Pharma Plc
2024/05/0920:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRNAVerona Pharma Plc
2024/05/0920:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRNAVerona Pharma Plc
2024/05/0920:15GlobeNewswire Inc.Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:VRNAVerona Pharma Plc
2024/05/0920:00GlobeNewswire Inc.Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERSNASDAQ:VRNAVerona Pharma Plc
2024/05/0215:00GlobeNewswire Inc.Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024NASDAQ:VRNAVerona Pharma Plc
2024/04/2515:00GlobeNewswire Inc.Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:VRNAVerona Pharma Plc
2024/03/0906:18Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VRNAVerona Pharma Plc
2024/03/0811:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VRNAVerona Pharma Plc
2024/03/0416:00GlobeNewswire Inc.Andrew Fisher Joins Verona Pharma as General CounselNASDAQ:VRNAVerona Pharma Plc
2024/02/2923:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VRNAVerona Pharma Plc
2024/02/2920:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRNAVerona Pharma Plc
2024/02/2916:00GlobeNewswire Inc.Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:VRNAVerona Pharma Plc
2024/02/1516:00GlobeNewswire Inc.Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate UpdateNASDAQ:VRNAVerona Pharma Plc
2024/02/0608:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRNAVerona Pharma Plc
2024/02/0608:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRNAVerona Pharma Plc
2024/02/0606:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRNAVerona Pharma Plc
2024/02/0220:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRNAVerona Pharma Plc
2024/02/0220:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VRNAVerona Pharma Plc
2024/02/0220:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRNAVerona Pharma Plc
2024/02/0116:00GlobeNewswire Inc.Michael Austwick Joins Verona Pharma as Non-Executive DirectorNASDAQ:VRNAVerona Pharma Plc
2024/01/0316:00GlobeNewswire Inc.Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:VRNAVerona Pharma Plc
2024/01/0220:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRNAVerona Pharma Plc
2024/01/0216:00GlobeNewswire Inc.Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules CapitalNASDAQ:VRNAVerona Pharma Plc
2023/12/1906:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRNAVerona Pharma Plc
2023/11/1716:00GlobeNewswire Inc.Verona Pharma’s President and CEO David Zaccardelli Wins Executive of the Year SCRIP AwardNASDAQ:VRNAVerona Pharma Plc
2023/11/0816:00GlobeNewswire Inc.Verona Pharma Announces November 2023 Investor Conference ParticipationNASDAQ:VRNAVerona Pharma Plc
2023/11/0409:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRNAVerona Pharma Plc
2023/11/0409:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRNAVerona Pharma Plc
 검색 관련기사 보기:NASDAQ:VRNA

최근 히스토리

NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
NYSE
BAC
Bank of America
NASDAQ
MSFT
Microsoft
CCOM
US100
US Tech 100
USOTC
BASFY
BASF (QX)
SPI
SP500
S&P 500
CCOM
US500
US 500
NYSE
MRK
Merck
NYSE
XOM
Exxon Mobil
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
USOTC
RHHBY
Roche (QX)
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유